Pharmacokinetics Study of Eplerenone Coated Tablets
Status:
Withdrawn
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the pharmacokinetics profile of the formulation of
eplerenone coated tablets in the concentration of 25mg, 50mg and 100mg (2 coated tablets of
50mg) in male and female healthy subjects under fasting condition.